You have 9 free searches left this month | to do more

rimiducid

Rimiducid is a drug used to treat Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Multiple Myeloma, and other conditions. Rimiducid is being actively studied in 11 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Bellicum PharmaceuticalsIRCCS Ospedale Pediatrico Bambino GesuJames Kochenderfer, M.D.
Poseida Therapeutics, Inc.Oregon Health & Science University
Fred Hutchinson Cancer Research CenterUniversity of California San Diego
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
No longer available
  • Hurler Syndrome
  • +4 more
  • rivogenlecleucel
  • rimiducid
  • Los Angeles, California
  • +1 more
2020-10-01
Oct 1, 2020
B
Active, not recruiting
  • Hematologic Malignancy
  • BPX-501 T cells
  • rimiducid
  • Pavia, Italy
  • +2 more
2020-10-01
Oct 1, 2020
N
Completed
  • Myeloma-Multiple
  • Myeloma, Plasma-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-08-19
Aug 19, 2021
P
Not yet recruiting
  • Multiple Myeloma
  • P-BCMA-ALLO1 CAR-T cells
  • Rimiducid
  • San Diego, California
  • +1 more
2021-10-29
Oct 29, 2021
U
Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-07-13
Jul 13, 2021
B
Withdrawn
  • Leukemia
  • +4 more
  • rivogenlecleucel
  • Rimiducid
  • (no location specified)
2020-10-01
Oct 1, 2020
B
Active, not recruiting
  • Leukemia
  • +4 more
  • BPX-501
  • Rimiducid
  • Atlanta, Georgia
  • +4 more
2020-10-01
Oct 1, 2020
B
Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • rivogenlecleucel
  • +3 more
  • Nashville, Tennessee
  • +1 more
2020-11-11
Nov 11, 2020
B
Unknown status
  • Acute Myeloid Leukemia
  • +2 more
  • BPX-701
  • Rimiducid
  • Denver, Colorado
  • +2 more
2020-04-23
Apr 23, 2020
B
Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +4 more
  • BPX-601
  • Rimiducid
  • Tampa, Florida
  • +6 more
2021-04-22
Apr 22, 2021
B
Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Rimiducid
  • rivogenlecleucel
  • Rome, Italy
  • +1 more
2020-10-01
Oct 1, 2020
P
Recruiting
  • Multiple Myeloma
  • P-BCMA-101 CAR-T cells
  • Rimiducid
  • Gilbert, Arizona
  • +15 more
2021-09-10
Sep 10, 2021
F
Withdrawn
  • Acute Bilineal Leukemia
  • +11 more
  • Rivogenlecleucel
  • Rimiducid
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2020-08-12
Aug 12, 2020
P
Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +10 more
  • P-PSMA-101 CAR-T cells
  • Rimiducid
  • Duarte, California
  • +7 more
2021-11-03
Nov 3, 2021
B
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • BPX-501 T cells
  • rimiducid
  • Roma, Italy
  • +3 more
2020-11-13
Nov 13, 2020
B
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
2020-10-01
Oct 1, 2020
B
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +8 more
  • BPX-501 T cells
  • Rimiducid
  • Los Angeles, California
  • +9 more
2020-10-01
Oct 1, 2020